Lipid nanoparticle mRNA systems containing high levels of sphingomyelin engender higher protein expression in hepatic and extra-hepatic tissues
splenocytes
bone marrow
QH573-671
mRNA
Genetics
hepatocytes
Original Article
lipid nanoparticles
QH426-470
Cytology
helper lipids
DOI:
10.1016/j.omtm.2023.06.005
Publication Date:
2023-06-12T06:25:29Z
AUTHORS (5)
ABSTRACT
Lipid nanoparticles (LNPs) for delivery of mRNA usually contain ionizable lipid/helper lipid/cholesterol/PEG-lipid in molar ratios 50:10:38.5:1.5, respectively. These LNPs are rapidly cleared from the circulation following intravenous (i.v.) administration, limiting uptake into other tissues. Here, we investigate properties LNP systems prepared with high levels "helper" lipids such as 1,2-distearoyl-sn-glycero-3-phosphorylcholine (DSPC) or N-(hexadecanoyl)-sphing-4-enine-1-phosphocholine (egg sphingomyelin [ESM]). We show that mRNAs containing 40 mol % DSPC ESM have a unique morphology small interior "solid" core situated an aqueous compartment is bounded by lipid bilayer. The encapsulated exhibits enhanced stability presence serum. exhibit significantly improved transfection vitro compared 10 ESM. When injected i.v., extended lifetimes DSPC, resulting accumulation extrahepatic Systems result gene expression spleen and bone marrow well liver post i.v. injection mRNAs. conclude helper provide new approach transfecting hepatic tissues.Graphical abstract
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (46)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....